FindTrial
Sign In

Effectiveness and satety,topical ganciclovir case of cytomegalovirus corneal endotheliitis

Effectiveness and satety,topical ganciclovir case of cytomegalovirus corneal endotheliitis - Effectiveness and satety,topical ganciclovir case of cytomegalovirus corneal endotheliitis

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026809
Enrollment
20
Registered
2017-03-31
Start date
2016-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cytomegalovirus corneal endotheliitis

Interventions

Administer 0.5% ganciclovir (ganciclovir 1A and saline 100 cc) 6 times a day

Sponsors

Toho university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: over 20years old Diagnosis with cytomegalovirus corneal endothelia agree with informed consent

Exclusion criteria

Exclusion criteria: less than 20years old sitivity for ganciclovir not agree with informed consent

Design outcomes

Primary

MeasureTime frame
(Effectiveness) 1 month,2 months,3 months,6 months after 1) Viral PCR by collecting anterior aqueous humor 2) visual acuity 3) Intra ocular pressure 4) corneal endothelium cells (safety) 1) hyperemia score 2) corneal epithelial damage 3) stimulation at eye drop 4) itching—

Countries

Japan

Contacts

Public ContactYukinobu Okajima

Toho univesity omori hospital General Affairs Division

yukinobu.okajima@med.toho-u.ac.jp03-3672-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026